KMID : 1011720170100020102
|
|
International Journal of Thyroidology 2017 Volume.10 No. 2 p.102 ~ p.106
|
|
Development of Graves¡¯ Ophthalmopathy after Radioactive Iodine Ablation Using Recombinant Human Thyrotropin for Incidentally Discovered Papillary Thyroid Carcinoma
|
|
Park Ji-Sun
|
|
Abstract
|
|
|
Several studies have revealed an association between radioactive iodine (RAI) therapy for Graves¡¯ disease and new or worsening Graves¡¯ ophthalmopathy. In the present case, thyroid papillary cancer was incidentally detected in a 43-year-old woman who was receiving medication for Graves¡¯ disease. This patient had undergone RAI ablation using recombinant human thyrotropin (rhTSH) after total thyroidectomy. The patient subsequently complained of a unilateral eyelid abnormality at approximately 6 months after the RAI ablation, and was diagnosed with bilateral Graves¡¯ ophthalmopathy after a thorough ophthalmological examination. I report this case for its interesting clinical features, rarity of occurrence and to highlight the importance of careful observation for appropriate management of Graves¡¯ ophthalmopathy developing or worsening after RAI ablation in differentiated thyroid cancer patients.
|
|
KEYWORD
|
|
ves¡¯ ophthalmopathy, Thyroid cancer, Recombinant human thyrotropin, Radioactive iodine
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|